BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 37407846)

  • 1. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
    Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
    Zuo H; Li MM
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.
    Xu D; He Y; Liao C; Tan J
    World J Surg Oncol; 2024 Jun; 22(1):151. PubMed ID: 38849854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.
    Shen J; Zhou Y; Yu B; Zhao K; Ding Y
    Eur J Surg Oncol; 2023 Oct; 49(10):106966. PubMed ID: 37365056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database.
    Zhang S; Xiao X; Qin X; Xia H
    Transl Cancer Res; 2023 Oct; 12(10):2742-2753. PubMed ID: 37969392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.
    He C; Ni M; Liu J; Teng X; Ke L; Matsuura Y; Okuda K; Sakairi Y; Cheng J; Yu L; Lv W; Hu J
    Transl Lung Cancer Res; 2024 Mar; 13(3):573-586. PubMed ID: 38601448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of two nomograms for predicting overall survival and Cancer-specific survival in prostate cancer patients with bone metastases: a population-based study.
    Li B; Xing J; Wang Z; Gong Z; Wang Z; Xu A
    BMC Urol; 2023 Dec; 23(1):200. PubMed ID: 38049755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
    Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
    Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
    J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the 2023 FIGO staging system: A nomogram for endometrioid endometrial cancer and adenocarcinoma.
    Feng Y; Miao F; Li Y; Li M; Cao Y
    Cancer Med; 2024 May; 13(10):e7216. PubMed ID: 38752451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of nomograms for predicting the survival of intestinal-type gastric adenocarcinoma patients after surgery.
    Liu CY; Yang YS; Ye K; He HF
    Sci Rep; 2023 Oct; 13(1):17430. PubMed ID: 37833383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China.
    Song Z; Ma H; Sun H; Li Q; Liu Y; Xie J; Feng Y; Shang Y; Ma K; Zhang N; Wang J
    BMC Cancer; 2023 Dec; 23(1):1182. PubMed ID: 38041067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a Prognostic Nomogram for Cancer-Specific Survival in Patients With Base-of-Tongue Squamous Cell Carcinoma: A Retrospective Study Based on the SEER Database.
    Lin ZJ; Huang L; Lin YM; Luo R; Wang SC; Lyu J; Shao J
    Cancer Control; 2023; 30():10732748231210733. PubMed ID: 37969067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy.
    Dai L; Yan W; Ren X; Liu D; Chang L; Lin S; Wu H; Kang H; Ma X
    Clin Breast Cancer; 2024 Jun; 24(4):351-362. PubMed ID: 38521702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
    Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
    Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for predicting cancer-specific survival in undifferentiated pleomorphic sarcoma: A Surveillance, Epidemiology, and End Results -based study.
    Xu F; Zhao F; Feng X; Li C; Han D; Zheng S; Liu Y; Lyu J
    Cancer Control; 2021; 28():10732748211036775. PubMed ID: 34405711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.
    Huang G; Liao J; Cai S; Chen Z; Qin X; Ba L; Rao J; Zhong W; Lin Y; Liang Y; Wei L; Li J; Deng K; Li X; Guo Z; Wang L; Zhuo Y
    Front Oncol; 2022; 12():949058. PubMed ID: 36237316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic nomogram and risk classification system of elderly patients with extraosseous plasmacytoma: a SEER database analysis.
    Chen Y; Tang M; Fu Y; Zhuang X; Wei R; Chen Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17921-17931. PubMed ID: 37955685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
    Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.